The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...
Main Authors: | Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2007
|
Subjects: |
Similar Items
-
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
by: Amin, A, et al.
Published: (2007) -
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
by: Otieno Dorothy N, et al.
Published: (2007-05-01) -
The decline in paediatric malaria admissions on the coast of Kenya
by: Okiro, E, et al.
Published: (2007) -
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
by: Zurovac, D, et al.
Published: (2007) -
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
by: Wasunna, B, et al.
Published: (2008)